Atrium Therapeutics, Inc. (RNA)
8.25
-0.15
(-1.79%)
USD |
NASDAQ |
Oct 29, 16:00
8.25
0.00 (0.00%)
After-Hours: 18:00
Atrium Therapeutics Price : 8.25 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 28, 2026 | 8.14 | 8.45 | 8.14 | 8.40 | 233598.0 |
| Oct 27, 2026 | 8.05 | 8.390 | 8.05 | 8.32 | 198573.0 |
| Oct 26, 2026 | 8.20 | 8.23 | 7.98 | 8.05 | 187418.0 |
| Oct 23, 2026 | 8.06 | 8.21 | 7.78 | 8.20 | 192660.0 |
| Oct 22, 2026 | 8.01 | 8.185 | 7.945 | 8.16 | 173482.0 |
| Oct 21, 2026 | 7.97 | 8.32 | 7.96 | 8.00 | 193208.0 |
| Oct 20, 2026 | 7.75 | 8.27 | 7.71 | 7.98 | 289489.0 |
| Oct 19, 2026 | 7.68 | 7.87 | 7.49 | 7.61 | 243914.0 |
| Oct 16, 2026 | 7.79 | 8.06 | 7.67 | 7.67 | 190979.0 |
| Oct 15, 2026 | 7.75 | 7.87 | 7.64 | 7.82 | 131237.0 |
| Oct 14, 2026 | 7.75 | 7.935 | 7.54 | 7.68 | 269494.0 |
| Oct 13, 2026 | 8.22 | 8.22 | 7.75 | 7.75 | 237188.0 |
| Oct 12, 2026 | 8.40 | 8.482 | 8.21 | 8.21 | 87396.00 |
| Oct 09, 2026 | 8.29 | 8.50 | 8.135 | 8.40 | 208349.0 |
| Oct 08, 2026 | 8.15 | 8.325 | 7.965 | 8.26 | 649310.0 |
| Oct 07, 2026 | 7.95 | 8.13 | 7.93 | 7.93 | 91819.00 |
| Oct 06, 2026 | 8.00 | 8.07 | 7.78 | 7.99 | 411686.0 |
| Oct 05, 2026 | 7.83 | 8.105 | 7.63 | 7.97 | 268285.0 |
| Oct 02, 2026 | 8.22 | 8.421 | 7.68 | 7.84 | 533806.0 |
| Oct 01, 2026 | 8.30 | 8.44 | 7.96 | 8.14 | 395724.0 |
| Sep 30, 2026 | 8.38 | 8.46 | 8.22 | 8.28 | 197306.0 |
| Sep 29, 2026 | 8.42 | 8.50 | 8.21 | 8.42 | 158804.0 |
| Sep 28, 2026 | 8.21 | 8.515 | 8.05 | 8.42 | 504915.0 |
| Sep 25, 2026 | 8.20 | 8.365 | 8.10 | 8.29 | 221427.0 |
| Sep 24, 2026 | 8.30 | 8.49 | 8.16 | 8.19 | 355242.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Tenax Therapeutics, Inc. | 1.865 |
| Exicure, Inc. | 0.94 |
| Century Therapeutics, Inc. | 1.455 |
| Absci Corp. | 12.10 |
| Celularity, Inc. | 0.8401 |
Price Related Metrics
| PS Ratio | 5.161 |
| PEG Ratio | -0.0057 |
| Price to Book Value | 0.6576 |
| Earnings Yield | -55.85% |
| Market Cap | 141.12M |
| PEGY Ratio | -0.0057 |